A team of cardiac surgeons from Clínica Universidad de Navarra (Spain) has been incorporated, for the first time in Spain, in two patients with coronary inadequacy, a new stent that prevents the complications of potential illnesses to avoid veins (bridges). This external chrome-cobalt outer prosthesis protects vein crafts (saphenous veins) whose coronary arteries have blocked are re-combined from far way.
The device, developed by the Israeli Graphic Solutions company, prevents the potential adverse events that venous crafts can suffer from replacing arterial sections that have been stimulated. Other complications include dilatation, internal surface change (intima) and, consequently, possible thrombotic episodes. It is estimated that these effects can occur in more than 40% of cases.
So far, the Clinic team, led by the Director of Galleries, Dr. Gregorio Rábago, along with Drs. Rebecca Manrique from Facundo Machado, has interrupted these devices to two patients "with very good results and excellent evolution," emphasizes the expert.
Heart failure in Spain affects about 7% of the population over 45, according to recent epidemiological studies (PRICE). The main cause of this inadequacy is its origin in the obstruction of coronary arteries due to the collection of cholesterol deposits in the arterial walls.
The experts in the Clinical Cardiac Surgery, Drs. Gregorio Rábago (director) and Facundo Machado, along with Dr. Rebecca Manrique, has successfully embedded the external stent in several patients. (Photo: U. Navarra)
Filling these boats prevents enough blood flow to supply the heart, so it can cause angina or a heart attack. Therefore, the patient with severe coronary disease should be interrupted to perform a bridge, bypass or bypass to jump the coronary section that has blocked.
According to various studies, the best way or avoiding surgery is considered to be a gold or best technique to treat coronary patients with three vessels, diabetes or coronary interventions, as it seeks to increase their longevity, reducing time & need for new re-outcomes.
These patients usually ask for an operation where they get 3 or 4 shillings. As mentioned previously, for those who bridge or avoid the maternity arteries and conventional fins of the legs are used conventionally. However, recently, cardiac surgeons have chosen that the mammary arteries are a priority because they respond better than veins to high blood pressure requirements.
Although, as Dr Rábago says, the barrier can affect such a way that the number of necessary outcomes exceeds both mammalian arteries, so sapaneous veins should be used. In these cases it becomes convenient to strengthen wildbars so that they react as arteries, avoiding the side effects already described. (Photo: U. Navarra)